Trial intelligence / Profile preview

ED90 of Remimazolam Anesthesia Induction in Pediatric Bidirectional Endoscopy

NCT06121609Completed

Sponsor
Tongji Hospital
Start
Jan 2024
Primary completion
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of remimazolam (3 arms), sponsored by Tongji Hospital. Primary endpoint: Modified Observer's Assessment of Alertness/Sedation Scale. Started Jan 2024; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on NCT06121609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06121609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call